
Study shows better reproducibility with devices dedicated to standardizing capsulorhexis
Study shows better reproducibility with devices dedicated to standardizing capsulorhexis
Biologic corneal bandage controls inflammation and promotes regenerative healing
What keeps everyone up at night? Disillusionment with continual change
Now an ophthalmologist, she travels the world helping restore sight to the needy
Market as predictor of demand for U.S. ophthalmologists?
Removing beta-carotene, adding lutein/zeaxanthin show clear patient benefits
Effectiveness depends on stage of the disease, mechanism of angle closure
LASIK results are good. Studies using current LASIK platforms routinely show 20/20 in excess of 80% of eyes and a high degree of satisfaction in 95% of patients. With about one million eyes treated annually, LASIK results are so good the U.S. military has accepted the procedure for combat pilots. But what about physicians?
While the control rate for uveal melanoma approaches 100%, disease-related mortality for this cancer has remained essentially unchanged over the past eight decades. According to Thomas M. Aaberg Jr., MD, identifying patients at greatest risk for metastasis and providing them with prophylactic treatment are key to altering mortality outcomes in the future.
Despite the damaging effects of ultraviolet radiation (UV) to the eyes and vision, 40% of adults in the United States say they do not wear sunglasses while outdoors.
The FDA has approved Bausch + Lomb’s Trulign lens, a toric posterior chamber IOL that corrects for astigmatism and has the capacity to deliver improved vision across a natural range of focus.
Justine Smith, FRANZCO, PhD, FARVO, of Flinders University, Adelaide, South Australia, is the new president of the Association for Research in Vision and Ophthalmology.
Valeant Pharmaceuticals International Inc. and Bausch + Lomb Holdings Inc. have entered into a definitive agreement, under which Valeant will acquire Bausch + Lomb.
Senators from the Health, Education, Labor and Pensions (HELP) Committee have introduced a revised version of its draft compounding bill to help improve the safety of compounded human and animal drugs.
Preliminary results of a preclinical study investigating the effect of peripheral collagen crosslinking (CXL) on the limbal stem cells provide some reassurance about the safety of the technique.
Two new studies add to the growing evidence that spending time outdoors may help prevent or minimize myopia in children.
New Jersey has enacted legislation that requires insurance companies and health plans to provide coverage for the early refill of prescription eye drops at 70% of the predicted days of use.
Survey results paint portrait of trends, technology’s effect on cataract practice
Lens demonstrated excellent rotational stability, visual outcomes in clinical trials
Corneal inlay allows presbyopia correction either paired with or after LASIK
Ian MacDonald, MSc, MD, talked about the future of gene therapy trials in choroideremia, a single-gene disorder that primarily affects the eye.
Cosmetic eyelash extensions and the adhesives used to apply them to eyelids can present dangers to consumers.
Ophthalmologists Leonard Flom, MD, and Aran Safir, MD, have been inducted into the National Inventors Hall of Fame for the invention of the iris recognition scanner.
Allegro Ophthalmics LLC and Senju Pharmaceutical Co. Ltd. have entered into a collaboration and agreement to develop and market Allegro’s integrin peptide therapy in Japan.
Once-daily dosing delivers rapid, potent control of postoperative pain, inflammation
Chemical enhancements to riboflavin solution aim to overcome need for epithelial debridement
Algorithm helps ophthalmologists decide best treatment option for patients based on data
Today’s options for patients with low vision go beyond traditional vision aids